Browsing: Head and Neck

A retrospective cohort study confirms mounting data that increasing nodal disease burden increases circulating tumor HPV-DNA levels (think: more is…

TORPEDO failed to demonstrate clinically meaningful long-term quality-of-life gains with the use of proton therapy for oropharyngeal cancer, instead exchanging…

This 357-patient cohort of oral tongue squamous cell carcinoma reveals predictive surgical volumetric thresholds—resection >two-thirds or tumor burden >one-third of…

Top Line: Can a topical carbon nanomaterial reduce radiation dermatitis in head and neck cancer patients? The Study: Fullerene is…

As outlined above, TORPEdO used an exhaustive list of OARs including anatomic substructures like the supraglottic larynx, glottis, the superior,…

Top Line: A recent US phase 3 trial made headlines with a suggestion of less toxicity translating to better survival…

Two trials have shown that adding PD-1 blockade to standard chemoradiation improves outcomes for locoregionally advanced nasopharyngeal carcinoma. DIPPER gave…

A pooled analysis of 23 phase 1-2 trials suggests neoadjuvant chemoimmunotherapy for resectable head and neck squamous cell carcinoma produces…

Top Line: Does shaving a week off treatment with 6 fractions per week improved outcomes for locally advanced HNSCC in…

Patient movement on the table during the time it takes to daily adapt treatment volumes can pose a tail-chasing quagmire,…